|
|
|
|
|
| You are here : Equity > Corporate Info > Balance Sheet |
|
|
Neuland Laboratories Ltd
|
Pharmaceuticals - Indian - Bulk Drugs
|
|
|
|
|
BSE Code :
|
524558
|
NSE Symbol :
|
NEULANDLAB
|
P/E :
|
64.51
|
|
|
|
ISIN Demat :
|
INE794A01010
|
Div & Yield % :
|
0.12
|
EPS :
|
186.59
|
|
|
|
Book Value :
|
1081.5200264
|
Market Cap( Cr.) :
|
15443.21
|
Face Value :
|
10
|
|
|
|
|
|
|
|
|
| | Mar 2024
( Cr) | Mar 2023
( Cr) | Mar 2022
( Cr) | Mar 2021
( Cr) | Mar 2020
( Cr) |
| | | | | | | | Share Capital | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 | | Reserves Total | 1,263.64 | 975.46 | 822.67 | 768.98 | 692.64 | | Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Total Shareholders Funds | 1,276.54 | 988.36 | 835.57 | 781.88 | 705.54 | | Secured Loans | 82.51 | 121.51 | 196.46 | 145.12 | 245.55 | | Unsecured Loans | 12.88 | 6.94 | 44.07 | 37.18 | 18.19 | | Total Debt | 95.39 | 128.45 | 240.53 | 182.30 | 263.74 | | Other Liabilities | 7.13 | 9.83 | 11.45 | 11.96 | 35.30 | | Total Liabilities | 1,379.06 | 1,126.64 | 1,087.55 | 976.14 | 1,004.58 | | | | | | | | Gross Block | 1,091.97 | 972.58 | 936.15 | 845.36 | 745.78 | | Less : Accumulated Depreciation | 268.31 | 215.05 | 168.79 | 129.53 | 93.22 | | Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Net Block | 823.66 | 757.53 | 767.36 | 715.83 | 652.56 | | Lease Adjustment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Capital Work in Progress | 45.89 | 40.57 | 20.46 | 17.25 | 23.75 | | Producing Properties | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Investments | 1.44 | 0.68 | 4.03 | 7.05 | 8.02 | | Current Assets, Loans & Advances | | | | | | | Inventories | 350.42 | 279.23 | 265.21 | 247.61 | 219.55 | | Sundry Debtors | 373.53 | 361.77 | 234.33 | 217.73 | 189.89 | | Cash and Bank Balance | 115.29 | 58.65 | 18.99 | 18.08 | 45.69 | | Loans and Advances | 80.23 | 60.69 | 57.35 | 58.30 | 51.21 | | Total Current Assets | 919.47 | 760.34 | 575.87 | 541.73 | 506.34 | | Less : Current Liabilities and Provisions | | | | | | | Current Liabilities | 390.89 | 383.50 | 237.57 | 287.75 | 175.93 | | Provisions | 1.64 | 11.89 | 1.21 | 0.64 | 2.27 | | Total Current Liabilities & Provisions | 392.53 | 395.39 | 238.78 | 288.39 | 178.21 | | Net Current Assets | 526.94 | 364.95 | 337.09 | 253.34 | 328.13 | | Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Deferred Tax Assets | 12.71 | 13.52 | 16.73 | 10.42 | 19.72 | | Deferred Tax Liability | 72.05 | 70.82 | 72.51 | 69.42 | 66.68 | | Net Deferred Tax | -59.34 | -57.30 | -55.78 | -59.00 | -46.96 | | Other Assets | 40.48 | 20.21 | 14.40 | 41.66 | 39.08 | | Total Assets | 1,379.07 | 1,126.64 | 1,087.56 | 976.13 | 1,004.59 | | Contingent Liabilities | 82.56 | 91.21 | 74.68 | 104.71 | 125.34 |
|
|
Loading....
|
|
|